CA3223134A1 - Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder - Google Patents

Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder Download PDF

Info

Publication number
CA3223134A1
CA3223134A1 CA3223134A CA3223134A CA3223134A1 CA 3223134 A1 CA3223134 A1 CA 3223134A1 CA 3223134 A CA3223134 A CA 3223134A CA 3223134 A CA3223134 A CA 3223134A CA 3223134 A1 CA3223134 A1 CA 3223134A1
Authority
CA
Canada
Prior art keywords
boulardii
marxianus
cerevisiae
composition
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3223134A
Other languages
English (en)
French (fr)
Inventor
Carlos DE LECEA
Jordi Cune Castellana
Maria Tintore Gazulla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mauri Uk Ltd AB
Original Assignee
Mauri Uk Ltd AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mauri Uk Ltd AB filed Critical Mauri Uk Ltd AB
Publication of CA3223134A1 publication Critical patent/CA3223134A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA3223134A 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder Pending CA3223134A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21382576.3 2021-06-30
EP21382576 2021-06-30
EP22382114 2022-02-11
EP22382114.1 2022-02-11
PCT/EP2022/068192 WO2023275323A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder

Publications (1)

Publication Number Publication Date
CA3223134A1 true CA3223134A1 (en) 2023-01-05

Family

ID=82308337

Family Applications (3)

Application Number Title Priority Date Filing Date
CA3223134A Pending CA3223134A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
CA3223303A Pending CA3223303A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions and uses thereof
CA3223136A Pending CA3223136A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions and uses thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA3223303A Pending CA3223303A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions and uses thereof
CA3223136A Pending CA3223136A1 (en) 2021-06-30 2022-06-30 Physiologically acceptable yeast compositions and uses thereof

Country Status (10)

Country Link
US (3) US20240316131A1 (cg-RX-API-DMAC7.html)
EP (3) EP4362710A1 (cg-RX-API-DMAC7.html)
JP (3) JP2024524501A (cg-RX-API-DMAC7.html)
KR (3) KR20240037257A (cg-RX-API-DMAC7.html)
AU (3) AU2022302361A1 (cg-RX-API-DMAC7.html)
CA (3) CA3223134A1 (cg-RX-API-DMAC7.html)
CO (3) CO2024000322A2 (cg-RX-API-DMAC7.html)
IL (3) IL309525A (cg-RX-API-DMAC7.html)
MX (3) MX2023015507A (cg-RX-API-DMAC7.html)
WO (3) WO2023275325A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3223134A1 (en) * 2021-06-30 2023-01-05 Carlos DE LECEA Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
WO2025104171A1 (en) * 2023-11-14 2025-05-22 Ab Mauri (Uk) Ltd Physiologically acceptable microbiological compositions comprising lactic acid bacteria and kluyveromyces marxianus yeast and uses thereof
CN117866854B (zh) * 2024-03-08 2024-06-07 广州同康生物科技有限公司 修复胃肠黏膜损伤的罗伊氏粘液乳杆菌bn01及其后生元
WO2025233827A1 (en) * 2024-05-10 2025-11-13 A. Menarini International Licensing S.A. Beneficial complementary symbiotic and mineral mix
EP4732843A1 (en) * 2024-10-22 2026-04-29 Lesaffre et Compagnie Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균
EA202090769A1 (ru) * 2018-05-04 2020-06-11 Борис Славинович ФАРБЕР Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом
CN111944725B (zh) * 2020-08-24 2021-12-07 汤臣倍健股份有限公司 一种副干酪乳杆菌207-27及其应用
CA3223134A1 (en) * 2021-06-30 2023-01-05 Carlos DE LECEA Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder

Also Published As

Publication number Publication date
MX2023015516A (es) 2024-03-15
CA3223303A1 (en) 2023-01-05
WO2023275323A9 (en) 2023-03-09
EP4362711A1 (en) 2024-05-08
US20240316131A1 (en) 2024-09-26
US20240293488A1 (en) 2024-09-05
MX2023015498A (es) 2024-03-04
JP2024526282A (ja) 2024-07-17
CO2024000322A2 (es) 2024-03-18
US20240325475A1 (en) 2024-10-03
EP4362712A1 (en) 2024-05-08
CO2024000323A2 (es) 2024-03-18
KR20240037257A (ko) 2024-03-21
CA3223136A1 (en) 2023-01-05
JP2024524502A (ja) 2024-07-05
JP2024524501A (ja) 2024-07-05
KR20240037256A (ko) 2024-03-21
WO2023275325A1 (en) 2023-01-05
AU2022303105A1 (en) 2024-02-01
IL309519A (en) 2024-02-01
WO2023275323A1 (en) 2023-01-05
WO2023275293A1 (en) 2023-01-05
AU2022303106A1 (en) 2024-02-01
IL309521A (en) 2024-02-01
MX2023015507A (es) 2024-04-26
AU2022302361A1 (en) 2024-02-01
EP4362710A1 (en) 2024-05-08
KR20240037981A (ko) 2024-03-22
CO2024000344A2 (es) 2024-04-18
IL309525A (en) 2024-02-01

Similar Documents

Publication Publication Date Title
US20240325475A1 (en) Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
US11492589B2 (en) Lactobacillus plantarum CJLP475 strain having antiviral and immunomodulatory effects and composition comprising the same
ES3035671T3 (en) Novel enterococcus faecium strains
RU2671209C2 (ru) Lactobacillus rhamnosus rht-3201, конъюгированные с полисахаридным полимерным связующим и их применение для профилактики или лечения атопических заболеваний
CN118354680A (zh) 用于治疗胃肠障碍的生理学上可接受的酵母菌组合物
US20130309212A1 (en) Lactobacillus salivarius and method for preparing metabolite thereof, composition of lactobacillus salivarius and metabolite thereof and use of the composition
KR20200007744A (ko) 락토바실러스 플란타럼 cjlp475 균주 및 락토바실러스 플란타럼 cjlp243 균주를 포함하는 조성물 및 이의 용도
JP2020529826A (ja) ラクトバチルス・プランタルムｃｊｌｐ４７５菌株とラクトバチルス・プランタルムｃｊｌｐ１７菌株とを含む組成物及びその用途
TW201609120A (zh) 含乳酸菌之腸道屏障功能促進劑
KR101909927B1 (ko) 케피어 유래 효모를 포함하는 프로바이오틱스
KR100855022B1 (ko) 락토바실러스 파라플란타룸 ｋｎｕｃ２５를 포함하는헬리코박터 파이로리 생육 억제용 조성물
KR101810862B1 (ko) 신규한 락토바실러스 카제이 wk3 균주 및 이의 용도
KR102244732B1 (ko) 프로바이오틱 초산균인 아세토박터 파스테리아누스 mglv 및 이의 면역조절 효과
US20250339478A1 (en) Mixed bifidobacterium strain with excellent productivity and anti-inflammatory activity, and uses thereof
WO2025104171A1 (en) Physiologically acceptable microbiological compositions comprising lactic acid bacteria and kluyveromyces marxianus yeast and uses thereof
KR20240115996A (ko) 신규 비피도박테리움 롱검 아종 인판티스 균주 및 이의 용도
CN121752284A (zh) 利用表达酒石酸脱水酶的菌株或包含其的联合疗法的、用于预防或治疗代谢性疾病的组合物
HK1226605A1 (en) Intestinal barrier function enhancer containing lactic acid bacteria

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250618

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250618